Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 125

Sort by

Sort Order Select

Journal Articles

Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapsed/refractory FLT3-mutated acute myeloid leukemia: A Japanese nationwide registry study

Blood (2025) 146 (Supplement 1): 4289.

https://doi.org/10.1182/blood-2025-4289

Published: 2025

Journal Articles

Serum albumin, but not gnri, is an independent prognostic factor for survival after first allogeneic SCT: A large-scale multicenter analysis

Blood (2025) 146 (Supplement 1): 2513.

https://doi.org/10.1182/blood-2025-2513

Published: 2025

Journal Articles

TP53 activation by the natural quassinoid brusatol enhances venetoclax efficacy and overcomes resistance in myeloid leukemias

Shin-ichiro Kawaguchi, Kazuya Sato, Junko Izawa, Norihito Takayama, Hiroko Hayakawa, Chiyoko Kato, Eiji Sakashita, Kaoru Tominaga, Hitoshi Endo, Yoshinobu Kanda

Blood (2025) 146 (Supplement 1): 1491.

https://doi.org/10.1182/blood-2025-1491

Published: 2025

Journal Articles

Development and evaluation of a protein language model-based prediction model for acute graft-versus-host disease in HLA-mismatched hematopoietic stem cell transplantation

Makoto Moriguchi, Soichiro Nakako, Hiroshi Okamura, Takakazu Kawase, Kyoko Fuse, Toshiki Terao, Kazuki Yoshimura, Noriko Doki, Takahiro Fukuda, Yuta Katayama, Tetsuya Eto, Kentaro Serizawa, Makoto Onizuka, Makoto Yoshimitsu, Yoshinobu Kanda, Ken Tabuchi, Yoshiko Atsuta, Junya Kanda, Makoto Murata

Blood (2025) 146 (Supplement 1): 4222.

https://doi.org/10.1182/blood-2025-4222

Published: 2025

Journal Articles

Differential trends in survival after allogeneic transplantation for MDS and MDS/MPN in a real-world experience

Blood (2025) 146 (Supplement 1): 3843.

https://doi.org/10.1182/blood-2025-3843

Published: 2025

Journal Articles

Nelarabine treatment before allogeneic stem cell transplantation was associated with an increased risk of neurological adverse events in patients with T-ALL/lbl: A retrospective study of the kanto study group for cell therapy.

Blood (2025) 146 (Supplement 1): 6043.

https://doi.org/10.1182/blood-2025-6043

Published: 2025

Journal Articles

Haploidentical hematopoietic stem cell transplantation using low-dose alemtuzumab is effective for standard-risk hematological malignancies

Blood (2025) 146 (Supplement 1): 5995.

https://doi.org/10.1182/blood-2025-5995

Published: 2025

Journal Articles

Optimizing patient selection to decrease non-relapse mortality with reduced intensity conditioning: A validation study using the CIBMTR dataset

Yu Akahoshi, Nelli Bejanyan, Hideki Nakasone, Machiko Kusuda, Yuma Tada, Emiko Sakaida, Yoshiko Atsuta, Yoshinobu Kanda, Takahiro Fukuda

Blood (2025) 146 (Supplement 1): 5978.

https://doi.org/10.1182/blood-2025-5978

Published: 2025

Journal Articles

Molecular Taxonomy Classification for Transplant Decision Making of Myelodysplastic Syndromes

Rurika Okuda, Yotaro Ochi, Tetsuichi Yoshizato, Yasuhito Nannya, Yoshiko Atsuta, Yuichi Shiraishi, Yusuke Shiozawa, Hiroko Tanaka, Makoto Onizuka, Kenichi Chiba, Hidehiro Itonaga, Yoshinobu Kanda, Yasushi Miyazaki, Keizo Horibe, Satoru Miyano, Hideki Makishima, Seishi Ogawa

Blood (2024) 144 (Supplement 1): 3203.

https://doi.org/10.1182/blood-2024-206498

Published: 2024

Journal Articles

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Blood (2024) 144 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2024-199077

Published: 2024

Journal Articles

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

Blood (2024) 144 (Supplement 1): 384.

https://doi.org/10.1182/blood-2024-203344

Published: 2024

Journal Articles

Prognostic Impact of Graft-Versus-Host Disease on Allogeneic Transplantation for CMML Focusing on Conditioning Intensity

Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Shuhei Kurosawa, Yasunobu Nagata, Yutaka Shimazu, Tomoaki Ueda, Naoyuki Uchida, Noriko Doki, Tetsuya Nishida, Ken-ichi Matsuoka, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Takayoshi Tachibana

Blood (2024) 144 (Supplement 1): 6755.

https://doi.org/10.1182/blood-2024-193699

Published: 2024

Journal Articles

Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database

Phillip Scheinberg, Tim H. H. Brummendorf, Regis Peffault De Latour, Carlo Dufour, Raj Gokani, Morag Griffin, Juliana Hey-Hadavi, Yoshinobu Kanda, Eric Mitchell, Barbara Możejko-Pastewka, Andres Quintero, Patryk Skowron, Meltem Kurt Yüksel, Alicia Rovó

Blood (2024) 144 (Supplement 1): 2329.

https://doi.org/10.1182/blood-2024-204908

Published: 2024

Journal Articles

Impact of Daratumumab on the Development of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

Blood (2024) 144 (Supplement 1): 6964.

https://doi.org/10.1182/blood-2024-202268

Published: 2024

Journal Articles

The Outcome of Fertility Preservation Strategy in Female Hematopoietic Stem Cell Transplant Recipients of Reproductive Age. Retrospective Study from the Kanto Study Group for Cell Therapy

Blood (2024) 144 (Supplement 1): 4925.

https://doi.org/10.1182/blood-2024-206182

Published: 2024

Journal Articles

Appropriate Threshold of Quantitative Cytomegalovirus DNA Polymerase Chain Reaction for Preemptive Treatment in Stem Cell Transplant Recipients

Blood (2024) 144 (Supplement 1): 4870.

https://doi.org/10.1182/blood-2024-207700

Published: 2024

Journal Articles

Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021

Blood (2024) 144 (Supplement 1): 4472.

https://doi.org/10.1182/blood-2024-206515

Published: 2024

Journal Articles

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2023) 142 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2023-181621

Published: 2023

Journal Articles

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Blood (2023) 142 (Supplement 1): 3609.

https://doi.org/10.1182/blood-2023-174431

Published: 2023

Journal Articles

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Kimimori Kamijo, Yoshimitsu Shimomura, Takayoshi Tachibana, Yuho Najima, Jun Aoki, Yu Akahoshi, Masatsugu Tanaka, Noriko Doki, Naoyuki Uchida, Hiroyuki Ohigashi, Hikaru Kobayashi, Shuichi Ota, Miho Nara, Shinichiro Fujiwara, Yasuo Mori, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasuyuki Arai

Blood (2023) 142 (Supplement 1): 4958.

https://doi.org/10.1182/blood-2023-180602

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapsed/refractory FLT3-mutated acute myeloid leukemia: A Japanese nationwide registry study

Serum albumin, but not gnri, is an independent prognostic factor for survival after first allogeneic SCT: A large-scale multicenter analysis

TP53 activation by the natural quassinoid brusatol enhances venetoclax efficacy and overcomes resistance in myeloid leukemias

Development and evaluation of a protein language model-based prediction model for acute graft-versus-host disease in HLA-mismatched hematopoietic stem cell transplantation

Differential trends in survival after allogeneic transplantation for MDS and MDS/MPN in a real-world experience

Nelarabine treatment before allogeneic stem cell transplantation was associated with an increased risk of neurological adverse events in patients with T-ALL/lbl: A retrospective study of the kanto study group for cell therapy.

Haploidentical hematopoietic stem cell transplantation using low-dose alemtuzumab is effective for standard-risk hematological malignancies

Optimizing patient selection to decrease non-relapse mortality with reduced intensity conditioning: A validation study using the CIBMTR dataset

Molecular Taxonomy Classification for Transplant Decision Making of Myelodysplastic Syndromes

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

Prognostic Impact of Graft-Versus-Host Disease on Allogeneic Transplantation for CMML Focusing on Conditioning Intensity

Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database

Impact of Daratumumab on the Development of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

The Outcome of Fertility Preservation Strategy in Female Hematopoietic Stem Cell Transplant Recipients of Reproductive Age. Retrospective Study from the Kanto Study Group for Cell Therapy

Appropriate Threshold of Quantitative Cytomegalovirus DNA Polymerase Chain Reaction for Preemptive Treatment in Stem Cell Transplant Recipients

Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only